Abstract

Introduction: Cardiac fibrosis, or excess deposition of extracellular matrix (ECM) within heart muscle, acts as a protective mechanism following cardiac injury, but causes long-term heart stiffening and impaired contraction. In vitro models aid in understanding cardiac disease mechanisms, but current fibrosis models lack (i) native-like ECM and (ii) interactions between multiple cardiac cell types. Objective: Our 3D model containing induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) and cardiac fibroblasts (CF) with exogenous ECM will reproducibly assess contractile changes under fibrotic conditions. Methods: Human GCaMP-encoded iPSC-CM (day 19) and CF (3:1) were combined in a custom agarose ring mold with collagen I (Col) (0.02 or 0.5 mg/mL), laminin (Lam) (0.01 mg/mL), both Col+Lam (0.03 mg/mL), Matrigel (0.03 mg/mL), or no ECM, n=5 for each condition. Concentrations were based on in vivo ratios of Col and Lam in literature. After 24 hours, cells self-assembled into 3D rings (Fig. 1a). Results: All conditions formed robust rings; average thickness = 460 μm (Fig.1b, c). Spontaneous beating resumed 48 hours after seeding. After 3 days in culture, Ca 2+ flux videos were captured; rings without ECM displayed shorter contraction durations, as did Col+Lam rings (Fig. 1d, e). This suggests that exogenous ECM in ratios found in healthy hearts may aid in contraction. Conclusion: This ring platform provides a reproducible cardiac fibrosis model with native-like ECM conditions and interactions between multiple cardiac cell types. Further assessments of ring stiffness and additional ECM conditions will enable this model to be used in therapeutic development.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call